Analgesic Efficacy and Safety of Topical VMD-3866 Gel in Management of Pain Induced by Chemotherapy (CIPN)
Analgesic Efficacy and Safety of Topical VMD-3866 Gel in Management of Pain Induced by Chemotherapy (CIPN)
Recruiting · NCT07072468 · Registry updated 2026-10-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Analgesic Efficacy and Safety of Topical VMD-3866 Gel in Management of Pain Induced by Chemotherapy (CIPN) | Chronic Pain, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hypesthesia, Male Urogenital Diseases, Neurologic Manifestations, Pain, Paresthesia, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, Somatosensory Disorders, Urogenital Diseases, kidney disorder, nervous system disorder, neuralgia, neuromuscular disease, peripheral nervous system disorder, urinary system disorder | Recruiting | Phase 2 | 2026-10-05 | NCT07072468 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| VM Therapeutics LLC | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hammersmith Medicines Research Ltd (24-503; Tel: 0800 783 8792; [email protected]) | London | United Kingdom | 1 |